Engineered Bio‐Based Hydrogels for Cancer Immunotherapy
Advanced Materials · 2024
DOI: 10.1002/adma.202313188 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, 2024. Verfasst von Yuxuan Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and P…. Hauptthemen laut MEDLINE: Hydrogels, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 296 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Medical Sciences, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Immunotherapy represents a revolutionary paradigm in cancer management, showcasing its potential to impede tumor metastasis and recurrence. Nonetheless, challenges including limited therapeutic efficacy and severe immune‐related side effects are frequently encountered, especially in solid tumors. Hydrogels, a class of versatile materials featuring well‐hydrated structures widely used in biomedicine, offer a promising platform for encapsulating and releasing small molecule drugs, biomacromolecules, and cells in a controlled manner. Immunomodulatory hydrogels present a unique capability for augmenting immune activation and mitigating systemic toxicity through encapsulation of multiple components and localized administration. Notably, hydrogels based on biopolymers have gained significant interest owing to their biocompatibility, environmental friendliness, and ease of production. This review delves into the recent advances in bio‐based hydrogels in cancer immunotherapy and synergistic combinatorial approaches, highlighting their diverse applications. It is anticipated that this review will guide the rational design of hydrogels in the field of cancer immunotherapy, fostering clinical translation and ultimately benefiting patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
- Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
- Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China.
ORCID-Profile: Lang Rao, Zhaohui Wang
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences
- CAMS Innovation Fund for Medical Sciences
- Beijing Natural Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Peng, Y., Liang, S., Meng, Q. F., Liu, D., Ma, K., Zhou, M., Yun, K., Rao, L., & Wang, Z. (2024). Engineered Bio‐Based Hydrogels for Cancer Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.202313188
Vancouver
Peng Y, Liang S, Meng QF, Liu D, Ma K, Zhou M, et al. Engineered Bio‐Based Hydrogels for Cancer Immunotherapy. Advanced Materials. 2024. doi:10.1002/adma.202313188
BibTeX
@article{Peng2024,
author = {Peng, Yuxuan and Liang, Shuang and Meng, Qian-Fang and Liu, Dan and Ma, Kongshuo and Zhou, Mengli and Yun, Kaiqing and Rao, Lang and Wang, Zhaohui},
title = {Engineered Bio‐Based Hydrogels for Cancer Immunotherapy},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202313188}
}
EUVIMED